On May 4, 2022, House Energy and Commerce (“E&C”) Committee leaders unveiled the legislative package to reauthorize the U.S. Food and Drug Administration (“FDA” or the “Agency”) user.
On April 12, 2022, CMS issued new guidance for the independent dispute resolution (“IDR”) process under the No Surprise Billing Rules (“Rules”) in response to a U.S. District Court for.
US Department of Health and Human Services HHS began an examination of guidance practices, and use of guidance, following the Supreme Court’s’ June 2019 decision in Azar v. Allina Health Services, et al. Court held that agency guidance that represents change in substantive legal standard
Individuals who thus far had refused to be vaccinated, citing medical, religious, or philosophical objections, challenged some vaccination mandates in courts. These lawsuits have had varying outcomes. The authors summarize the most significant recent deci